Editorials Polypharmacy and comorbidity in heart failure BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7414.513 (Published 04 September 2003) Cite this as: BMJ 2003;327:513 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527 An older man with thoracic back pain BMJ November 23, 2016, 355 i5786; DOI: https://doi.org/10.1136/bmj.i5786 Potential role for BCG in treatment of autoimmune diseases BMJ November 21, 2016, 355 i6091; DOI: https://doi.org/10.1136/bmj.i6091 Risks of duloxetine for stress incontinence outweigh benefits, say researchers BMJ November 15, 2016, 355 i6103; DOI: https://doi.org/10.1136/bmj.i6103 Haematospermia BMJ November 10, 2016, 355 i5124; DOI: https://doi.org/10.1136/bmj.i5124 Cited by... Managing Patients With Heart Failure: A Qualitative Study of Multidisciplinary Teams With Specialist Heart Failure NursesAbstract Fulltext PDF
